Skip to main content
. 2022 Mar 17;22:98. doi: 10.1186/s12883-022-02607-3

Table 1.

Clinical characteristics of participating patients at baseline

Active Sham P-value
Number of patients 5 5
Age* 58.8 (5.9) 59.2 (17.5) 0.97
Time since stroke (days)* 35.2 (21.7) 47.4 (25.0) 0.43
Gender - male:female 1:4 1:4 1.00a
Type of stroke
 - Ischemic stroke 4 4 1.00 a
 - Hemorrhagic stroke 1 1
Side of brain lesion
 - Left 3 3 1.00 a
 - Right 2 2
Education
 - Primary school 2 2 0.34b
 - Secondary school 2 0
 - Vocational certificate 1 2
 - Higher education 0 1
MRC-UE* 2.80 (1.09) 2.20 (2.05) 0.58
MRC-LE* 1.20 (1.30) 2.00 (1.87) 0.45
BS-ARM* 3.60 (0.89) 3.20 (1.09) 0.54
BS-HAND* 2.80 (1.30) 3.00 (1.00) 0.79
FMA-UE* 23.40 (13.47) 21.40 (12.68) 0.81
WMFT-FAS* 28.40 (11.72) 28.20 (15.01) 0.98
WMFT-TIME* 87.69 (20.71) 89.51 (29.76) 0.91

MRC-UE Medical Research Council scale of upper extremity, MRC-LE Medical Research Council scale of lower extremity, FMA-UE Fugl-Meyer upper extremity motor score, WMFT-FAS Wolf motor function test - Functional ability, WMFT-TIME Wolf motor function test-Performance time

aP-value by Fisher’s Exact test

bP-value by Chi-squared test

*Mean (standard deviation); p-value by Independence t-test